Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129 by Badimon, Lina, Robinson, Emma L, Jusic, Amela, Carpusca, Irina, deWindt, Leon J, Emanueli, Costanza, Ferdinandy, Péter, Gu, Wei, Gyöngyösi, Mariann, Hackl, Matthias, Karaduzovic-Hadziabdic, Kanita, Lustrek, Mitja, Martelli, Fabio, Nham, Eric, Potočnjak, Ines, Satagopam, Venkata, Schneider, Reinhard, Thum, Thomas, Devaux, Yvan

Get full text

Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy by Lips, Daniel J., deWindt, Leon J., van Kraaij, Dave J.W., Doevendans, Pieter A.

Get full text

The MEF2 transcriptional target DMPK induces loss of sarcomere structure and cardiomyopathy by Damanafshan, Amin, Elzenaar, Ies, Samson-Couterie, Benoit, van der Made, Ingeborg, Bourajjaj, Meriem, van den Hoogenhof, Maarten M, van Veen, Henk A, Picavet, Daisy I, Beqqali, Abdelaziz, Ehler, Elisabeth, De Windt, Leon J, Pinto, Yigal M, van Oort, Ralph J

Get full text

Loss of NF-ATc3, not NF-ATc4, attenuates cardiac hypertrophy induced by calcineurin activation in vivo by Wilkins, Benjamin J., DeWindt, Leon J., Bueno, Orlando F., Braz, Julian C., Molkentin, Jeffery D.

Get full text

Myocyte apoptosis in heart failure by VAN EMPEL, Vanessa P. M, BERTRAND, Anne T. A, HOFSTRA, Leo, CRIJNS, Harry J, DOEVENDANS, Pieter A, DE WINDT, Leon J

Get full text

Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts by TEUNISSEN, Birgit E. J, SMEETS, Pascal J. H, WILLEMSEN, Peter H. M, DE WINDT, Leon J, VAN DER VUSSE, Ger J, VAN BILSEN, Marc

Get full text

TOLL-erating cardiac hypertrophy following pressure overload by van Oort, Ralph J., De Windt, Leon J.

Get full text

Human heart failure: our current STATus of knowledge by van Empel, Vanessa P M, De Windt, Leon J

Get full text